ACB

MKT CAP:$193M

Aurora Cannabis Inc.

Market Cap

$193M

Healthcare·Drug Manufacturers - Specialty & Generic·🇨🇦 Canada·NASDAQ

Healthcare·Drug·🇨🇦·NASDAQ

Stock Price

$3.28-$1.06 (-24.42%)

Apr 23, 2026

Company Details

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product...

CEO

Miguel Martin

IPO Date

Jul 15, 2014

Website

www.auroramj.com

Key Metrics TTM

Revenue

$165M

+10.9% YoY

Net Income

-$1.3B

EPS (Diluted)

-$55.75

Free Cash Flow

-$90M

Revenue / Share

$3.48

Gross Margin

9.2%

Operating Margin

-92.9%

Net Margin

-763.4%

FCF Margin

-54.7%

P/S

1.2x

P/E

—

Earnings Reports

Q3 2024

Dec 30, 2023

$47MEPS -$0.38

Q1 2023

Jun 29, 2022

$37MEPS -$18.16

FY 2022

Jun 29, 2022

$162M-9.8%EPS -$58.40

Q4 2022

Mar 31, 2022

$37M-8.6%EPS -$34.46

Q3 2022

Dec 30, 2021

$44MEPS -$2.76

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 16	$160.2K	$3M	$2M
Q1 17	$891.6K	-$3M	-$2M
Q2 17	$2M	$62.8K	-$2M
Q3 17	$3M	$3M	-$2M
Q4 17	$4M	$4M	-$1M
Q1 18	$4M	$4M	-$3M
Q2 18	$6M	$6M	-$1M
Q4 18	$12M	$6M	-$23M
Q1 21	$53M	-$106M	-$154M
Q4 21	$40M	-$60M	-$102M
Q2 22	$44M	$19M	-$29M
Q3 22	$44M	$4M	-$41M
Q4 22	$37M	-$10M	-$53M
Q1 23	$37M	$3M	-$47M
Q3 24	$47M	$18M	-$13M

Valuation

Quarter	P/S	P/E
Q4 16	—	—
Q1 17	—	—
Q2 17	—	—
Q3 17	31.5x	—
Q4 17	19.8x	—
Q1 18	14.6x	—
Q2 18	11.4x	—
Q4 18	7.5x	—
Q1 21	2.6x	—
Q4 21	1.7x	—
Q2 22	1.3x	—
Q3 22	1.1x	—
Q4 22	1.2x	—
Q1 23	1.2x	—
Q3 24	1.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 16	-$2M	-$3M
Q1 17	-$1M	-$1M
Q2 17	-$2M	-$3M
Q3 17	-$2M	-$5M
Q4 17	-$7M	-$13M
Q1 18	$3M	-$6M
Q2 18	-$4M	-$19M
Q4 18	-$20M	-$52M
Q1 21	-$36M	-$61M
Q4 21	-$42M	-$51M
Q2 22	-$17M	-$20M
Q3 22	-$16M	-$25M
Q4 22	-$28M	-$33M
Q1 23	-$19M	-$26M
Q3 24	-$4M	-$6M

Capital Expenditures

Quarter	CapEx
Q4 16	$507.6K
Q1 17	$203.5K
Q2 17	$460.4K
Q3 17	$3M
Q4 17	$6M
Q1 18	$9M
Q2 18	$15M
Q4 18	$32M
Q1 21	$25M
Q4 21	$9M
Q2 22	$3M
Q3 22	$9M
Q4 22	$5M
Q1 23	$7M
Q3 24	$2M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 17	+2260.5%	+386.1%
Q1 18	+386.5%	+164.1%
Q2 18	+168.6%	+52.3%
Q4 18	+314.5%	+650.3%
Q1 21	+1293.5%	+3931.6%
Q4 21	+829.3%	+1912.6%
Q2 22	+628.7%	+929.1%
Q3 22	+276.3%	+147.7%
Q4 22	-30.1%	-56.5%
Q1 23	-9.0%	-41.2%
Q3 24	+7.1%	-17.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 16	$81.3K	50.8%
Q1 17	$148.6K	16.7%
Q2 17	$277.7K	12.4%
Q3 17	$2M	64.6%
Q4 17	$2M	50.9%
Q1 18	$2M	34.7%
Q2 18	$2M	30.1%
Q4 18	$12M	98.6%
Q1 21	$4M	8.3%
Q4 21	$4M	9.5%
Q2 22	$2M	4.7%
Q3 22	$3M	6.4%
Q4 22	$3M	7.0%
Q1 23	$3M	6.9%
Q3 24	$2M	4.4%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 16	$79.8K	$586.9K	$336.6K
Q1 17	$182.9K	$938.1K	$626.4K
Q2 17	$29.2K	$1M	$1M
Q3 17	$72.3K	$3M	$2M
Q4 17	$38.0K	$3M	$2M
Q1 18	$89.8K	$3M	$3M
Q2 18	$78.2K	$4M	$3M
Q4 18	$348.6K	$19M	$4M
Q1 21	$6M	$18M	$12M
Q4 21	$2M	$25M	$10M
Q2 22	$3M	$24M	$11M
Q3 22	$1M	$24M	$10M
Q4 22	$2M	$20M	$12M
Q1 23	$2M	$25M	$12M
Q3 24	$571.5K	$18M	$9M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$163M	$0	$163M
Q1 23	$357M	$972.4K	$358M
Q2 23	$310M	$271.5K	$310M
Q3 23	$234M	$136.2K	$235M
Q4 23	$220M	$0	$220M
Q1 24	$163M	$0	$163M
Q2 24	$140M	$0	$140M
Q3 24	$150M	$3M	$153M
Q4 24	$131M	$3M	$134M
Q1 25	$133M	$0	$133M
Q2 25	$111M	$0	$111M
Q3 25	$132M	$0	$132M
Q4 25	$135M	$402.5K	$135M
Q1 26	$137M	$0	$137M
Q2 26	$70M	$0	$70M
Q3 26	$41M	$38M	$79M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 16	1M	—	—
Q1 17	1M	-6.9%	—
Q2 17	2M	+35.6%	—
Q3 17	2M	+43.7%	—
Q4 17	3M	+18.7%	+115.2%
Q1 18	3M	+14.0%	+163.4%
Q2 18	3M	+5.4%	+104.9%
Q4 18	4M	+27.3%	+81.5%
Q1 21	11M	+179.1%	+326.9%
Q4 21	19M	+74.1%	+552.0%
Q2 22	20M	+2.2%	+531.8%
Q3 22	20M	+0.1%	+396.6%
Q4 22	21M	+8.3%	+92.7%
Q1 23	25M	+16.0%	+28.4%
Q3 24	47M	+90.5%	+139.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 16	—	—
Q1 17	—	—
Q2 17	—	—
Q3 17	—	—
Q4 17	—	—
Q1 18	—	—
Q2 18	—	—
Q4 18	—	—
Q1 21	$26M	2
Q4 21	$20M	2
Q2 22	$22M	2
Q3 22	$22M	2
Q4 22	$18M	2
Q1 23	$18M	2
Q3 24	$24M	2

Revenue / Employee